Screen Reader Mode Icon

Instructions

In order for our program to qualify for CME credit, we need to gauge the success of learning objectives this program.  Please complete the questions below in order to for us to provide ongoing CME.

We will forward your CME certificate to the email provided below once we have received your post eval and quiz.

Question Title

* 1. Physician Name

Question Title

* 2. Texas Medical License Number (for TMA/CME purposes)

Question Title

* 3. Physician's Date of Birth

Date

Question Title

* 4. Physician's Individual NPI Number (if you have it handy)

Question Title

* 5. Physician Email

Question Title

* 6. Physician Phone Number (preferably one used on zoom call)

Question Title

* 7. Do you believe the content of this session was valuable?

Question Title

* 8. As a result of participating on the conference call/zoom meeting, do you intend to make changes to your practice/treatment regimens?

Question Title

* 9. Did you learn new information related to treatment practices that will benefit your patients?

Question Title

* 10. Do you have a greater understanding of when:
1) to give background on blood bank services and best practices in blood utilization.
2. to provide current recognized AABB transfusion reactions and ways to recognize them.

Question Title

* 11. According to the 1999 TRICC (Transfusion Requirements in Critical Care) Trial (NEJM), what was the Hgb level that was found to be the ideal restrictive transfusion trigger.  This excluded ALL patients with serious cardiac disease.

Question Title

* 12. Don't proceed with elective surgery in patients with properly diagnosed and correctable anemia until the anemia has been appropriately treated.

Question Title

* 13. Transfusion Associated Cardiac Overload (TACO) in comparison to Transfusion Associated Lung Injury (TRALI) both recognized transfusion reactions by the AABB, can be differentiated by what findings:

Question Title

* 14. What is a key differentiating laboratory finding that can be seen in intravascular hemolysis, in contrast to extravascular hemolysis?

Question Title

* 15. In a hemodynamically stable, non-bleeding patient, what is the best strategy to prevent and recognize a potential transfusion reaction early?

Question Title

* 16. Was the content free of commercial bias?

Question Title

* 17. Comments?

0 of 17 answered
 

T